Petros Pharmaceuticals to Participate at the Investor Summit Conference and Present to Investors on May 18, 2021
Petros Pharmaceuticals (Nasdaq: PTPI) announced its participation at the Investor Summit Conference on May 18, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Petros Pharmaceuticals (Nasdaq: PTPI) announced its participation at the Investor Summit Conference on May 18, 2021. President and Chief Commercial Officer Fady Boctor will present at 9:30am ET. Investors can also arrange one-on-one meetings with Mr. Boctor after the conference. The company aims to lead in men's health therapeutics, focusing on issues like erectile dysfunction and Peyronie's disease. Interested investors can register for the conference here.
Details
News Market Reaction – PTPI
The recorded move for PTPI in the trading session of this news was +0.34%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, May 14, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that management will participate at the Investor Summit Conference on May 18, 2021.
President and Chief Commercial Officer Fady Boctor will deliver his corporate presentation at 9:30am ET on May 18, 2021.
Investors can also request a one-on-one meeting with Mr. Boctor to be arranged following the conclusion of the conference.
Investors can register for the conference here.
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
View original content:http://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-participate-at-the-investor-summit-conference-and-present-to-investors-on-may-18-2021-301291542.html
SOURCE Petros Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.